Parag Joshi, MD, FACC

General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Regeneron(SIGNIFICANT), Bayer Healthcare Pharmaceuticals(SIGNIFICANT) RESEARCH/RESEARCH GRANTS: Sanofi/Regeneron(NONE), AstraZeneca Pharmaceuticals(NONE), GlaxoSmithKline(NONE), Novo Nordisk Inc.(SIGNIFICANT) OTHER FINANCIAL BENEFIT: Global genomics group(SIGNIFICANT)

View Full Disclosure